thyroid cancer

Showing 26 - 50 of 273

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Thyroid Cancer, Thyroid, Refractory Thyroid Cancer Trial in New York (Surveillance Visit)

Recruiting
  • Thyroid Cancer
  • +2 more
  • Surveillance Visit
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Feb 8, 2023

Cancer, Solid Tumor, Melanoma Trial (KVA12123 - Dose Escalation, KVA12123 Plus Pembrolizumab - Dose Escalation, KVA12123 - Dose

Not yet recruiting
  • Cancer
  • +16 more
  • KVA12123 - Dose Escalation
  • +3 more
  • (no location specified)
Feb 2, 2023

Thyroid Cancer Trial run by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (drug, radiation,

Recruiting
  • Thyroid Cancer
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 28, 2023

Studies on Tumors of the Thyroid

Recruiting
  • Hurthle Cell Thyroid Cancer
  • +4 more
  • 68-Gallium Dotatate
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 26, 2023

Thyroid Cancer, Thyroid Cancer, Follicular, Papillary Thyroid Cancer Trial in United States (Trametinib, Dabrafenib, PDR001)

Recruiting
  • Thyroid Cancer
  • +6 more
  • Basking Ridge, New Jersey
  • +6 more
Jan 19, 2023

Advanced Cancer, Anal Carcinoma, Anal Cancer Trial in Worldwide (pembrolizumab)

Recruiting
  • Advanced Cancer
  • +24 more
  • pembrolizumab
  • Los Angeles, California
  • +21 more
Jan 18, 2023

Thyroid Cancer Trial in Toulouse, Montpellier (Signature of 10 microRNA for patients with bethesda classification 3, 4 or 5)

Recruiting
  • Thyroid Cancer
  • Signature of microRNA for patients with bethesda classification 3, 4 or 5
  • Toulouse, Haute-Garonne, France
  • +1 more
Jan 13, 2023

Near-Infrared Autofluorescence With PTH Test Strip asSOP of

Recruiting
  • Thyroid Cancer
  • +2 more
  • Near-infrared devices
  • PTH test strip
  • FuZhou, Fujian, China
    Fujian Medical University Union Hospital
Jan 4, 2023

Ovarian Cancer, Cervical Cancer, Endometrial Cancer Trial in Worldwide (Enapotamab vedotin (HuMax-AXL-ADC))

Completed
  • Ovarian Cancer
  • +7 more
  • Enapotamab vedotin (HuMax-AXL-ADC)
  • Phoenix, Arizona
  • +40 more
Dec 12, 2022

Head Neck Cancer, Spinal Accessory Nerve Injury, Thyroid Cancer Trial (Myofascial Release Technique, Exercise, Scar Tissue

Recruiting
  • Head and Neck Cancer
  • +5 more
  • Myofascial Release Technique
  • +2 more
  • Istanbul, Turkey
    Yeditepe University Hospital
Jan 1, 2023

Thyroid Cancer, Thyroid Carcinoma, Metastatic Thyroid Cancer Trial in Boston (Selpercatinib, Sodium Iodine I-131, rhTSH)

Not yet recruiting
  • Thyroid Cancer
  • +5 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Dec 20, 2022

Human Thyroid and Iodine Resistance

Recruiting
  • Thyroid Cancer
  • Metabolites dosage
  • Toulouse, France
    Institut Claudius regaud IUCT Oncopole
Dec 22, 2022

Thyroid Cancer Trial in Chengdu (Tislelizumab, Anlotinib, Radiotherapy)

Recruiting
  • Thyroid Cancer
  • Chengdu, Sichuan, China
    Xingchen Peng
Dec 17, 2022

Cancer, Cancer Metastatic, Tumors Trial in Los Angeles (Virtual group based physical activity (BurnAlong) and Social Media

Recruiting
  • Cancer
  • +21 more
  • Virtual group based physical activity (BurnAlong) and Social Media Discussion Board
  • Los Angeles, California
    Cedars-Sinai Medical Center
Dec 7, 2022

Validation for Early Cancer Detection and Minimal Residual

Recruiting
  • Brain Cancer
  • +19 more
    • Duarte, California
    • +6 more
    Nov 10, 2022

    Thyroid Cancer, Anaplastic Thyroid Cancer, Undifferentiated Thyroid Cancer Trial in Stanford (Abemaciclib)

    Active, not recruiting
    • Thyroid Cancer
    • +2 more
    • Stanford, California
      Stanford University
    Nov 8, 2022

    Pancreatic Cancer, Small Bowel Cancer, Colorectal Cancer Trial in United States (Ulixertinib (BVD-523))

    Available
    • Pancreatic Cancer
    • +20 more
    • Ulixertinib (BVD-523)
    • Birmingham, Alabama
    • +25 more
    Nov 4, 2022

    Adenocarcinoma, Adenocystic Carcinoma, Anal Cancer Trial in Idaho Falls (diagnostic test, drug, other)

    Recruiting
    • Adenocarcinoma
    • +75 more
    • Biomarker Testing (L)
    • +2 more
    • Idaho Falls, Idaho
    • +1 more
    Oct 18, 2022

    Thyroglobulin and Galectin-3 for Prognosis and Follow-up in

    Recruiting
    • Thyroid Cancer
    • +2 more
      • Taipei, Taiwan
        Chih-Yuan Wang, M.D
      Oct 16, 2022

      Thyroid Cancer, Thyroid Nodule Trial in Gothenburg (Non-selective cytology)

      Recruiting
      • Thyroid Cancer
      • Thyroid Nodule
      • Non-selective cytology
      • Gothenburg, Sweden
        Department of radiology, Sahlgrenska University Hospital
      Oct 13, 2022

      Postoperative Hypoparathyroidism, Thyroid Disease, Thyroid Tumors Trial in Milwaukee (NIRAF Detection Technology)

      Recruiting
      • Postoperative Hypoparathyroidism
      • +3 more
      • NIRAF Detection Technology
      • Milwaukee, Wisconsin
        Froedtert Hospital and Medical College of Wisconsin
      Oct 11, 2022

      Thyroid Cancer, Graves Disease Trial in Baltimore (Cervical Collar Therapy Indicator (COTI))

      Recruiting
      • Thyroid Cancer
      • Graves Disease
      • Cervical Collar Therapy Indicator (COTI)
      • Baltimore, Maryland
        Johns Hopkins Hospital
      Oct 5, 2022

      Low-risk Papillary Thyroid Cancer, Endocrine Malignancy, Thyroid Cancer Trial run by the NCI (Total Thyroidectomy (TT),

      Terminated
      • Low-risk Papillary Thyroid Cancer
      • +2 more
      • Total Thyroidectomy (TT)
      • Prophylactic central neck lymph node dissection (pCND)
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Sep 8, 2022

      A Taiwanese Oncogenetic Panel and Integrated Clinical Data

      Recruiting
      • Thyroid Cancer
      • A Taiwanese Oncogenetic Panel and Integrated Clinical Data Registry Study for Advanced Thyroid Cancer Patients
      • Kaohsiung, Taiwan
      • +7 more
      Sep 12, 2022